UB Paderborn / Katalog / Suche / in CDI

Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood

Clinical science (1979), 2017-07, Vol.131 (14), p.1579

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease

Brain pathology (Zurich, Switzerland), 2016-07, Vol.26 (4), p.533-541

2016

Link zum Volltext

Verfügbarkeit prüfen

Pericyte Contractile Responses to Endothelin-1 and Aβ Peptides: Assessment by Electrical Impedance Assay

Frontiers in cellular neuroscience, 2021-08, Vol.15, p.723953-723953

2021

Link zum Volltext

Verfügbarkeit prüfen

Cerebrovascular disease in ageing and Alzheimer’s disease

Acta Neuropathologica, 2016-05, Vol.131 (5), p.645-658

2016

Link zum Volltext

Verfügbarkeit prüfen

White Matter Hypoperfusion and Damage in Dementia: Post-Mortem Assessment

Brain pathology (Zurich, Switzerland), 2015-01, Vol.25 (1), p.99-107

2015

Link zum Volltext

Verfügbarkeit prüfen

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease

Journal of cerebral blood flow and metabolism, 2018-01, Vol.38 (1), p.103-115

2018

Link zum Volltext

Verfügbarkeit prüfen

A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease

Nature communications, 2024-03, Vol.15 (1), p.2243-2243, Article 2243

2024

Link zum Volltext

Verfügbarkeit prüfen

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease

Translational psychiatry, 2024-01, Vol.14 (1), p.3-3, Article 3

2024

Link zum Volltext

Verfügbarkeit prüfen

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging

PloS one, 2013-10, Vol.8 (10), p.e78806

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Brain pathology (Zurich, Switzerland), 2022-11, Vol.32 (6), p.e13061-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia

Brain pathology (Zurich, Switzerland), 2021-07, Vol.31 (4), p.e12935-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease

Brain (London, England : 1878), 2021-07, Vol.144 (6), p.1869-1883

2021

Link zum Volltext

Verfügbarkeit prüfen

Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease

Brain pathology (Zurich, Switzerland), 2016-09, Vol.26 (5), p.607-617

2016

Link zum Volltext

Verfügbarkeit prüfen

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ

Brain pathology (Zurich, Switzerland), 2017-05, Vol.27 (3), p.305-313

2017

Link zum Volltext

Verfügbarkeit prüfen

Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage

PloS one, 2013-04, Vol.8 (4), p.e59554-e59554

2013

Link zum Volltext

Verfügbarkeit prüfen

Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease

The journals of gerontology. Series A, Biological sciences and medical sciences, 2022-09, Vol.77 (9), p.1775-1783

2022

Link zum Volltext

Verfügbarkeit prüfen

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease

Aging brain, 2023-01, Vol.3, p.100062-100062, Article 100062

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 targets pericytes to restrict blood flow within the brain

Brain (London, England : 1878), 2023-02, Vol.146 (2), p.418-420

2023

Link zum Volltext

Verfügbarkeit prüfen

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease

Acta neuropathologica communications, 2019-04, Vol.7 (1), p.57-57, Article 57

2019

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology

Alzheimer's research & therapy, 2016-11, Vol.8 (1), p.50-50, Article 50

2016

Link zum Volltext

Verfügbarkeit prüfen

ACE variants and association with brain Aβ levels in Alzheimer's disease

American journal of translational research, 2010-10, Vol.3 (1), p.73-80

2010

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology

Journal of Alzheimer's disease, 2017-01, Vol.58 (1), p.203

2017

Link zum Volltext

Verfügbarkeit prüfen

Altered Gene Expression Within the Renin-Angiotensin System in Normal Aging and Dementia

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-01, Vol.79 (1)

2024

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors

Journal of Virology, 2005-09, Vol.79 (18), p.12016-12024

2005

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease

Alzheimer's research & therapy, 2014-12, Vol.6 (5-8), p.77-77, Article 77

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease

Pericyte Contractile Responses to Endothelin-1 and Aβ Peptides: Assessment by Electrical Impedance Assay

Cerebrovascular disease in ageing and Alzheimer’s disease

White Matter Hypoperfusion and Damage in Dementia: Post-Mortem Assessment

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease

A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia

Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease

Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ

Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage

Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease

SARS-CoV-2 targets pericytes to restrict blood flow within the brain

Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease

Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology

ACE variants and association with brain Aβ levels in Alzheimer's disease

Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology

Altered Gene Expression Within the Renin-Angiotensin System in Normal Aging and Dementia

Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease

Suchergebnisse filtern